ReviewJournal of multidisciplinary healthcare2025
Hydrogel-Based Biomaterials in Spinal Repair: Evaluating Mechanisms for IVDD, SCI, and Dural Regeneration.
Review in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal disorders, such as intervertebral disc degeneration (IVDD) and spinal cord injury (SCI), pose substantial challenges in modern healthcare, exacerbated by an aging population and the limited effectiveness of current treatments. IVDD, characterized by extracellular matrix (ECM) degradation, dehydration of the nucleus pulposus, and inflammation, is a leading cause of chronic low back pain, affecting approximately 266 million people worldwide each year. Likewise, SCI, frequently resulting from traumatic incidents, can induce irreversible neurological impairment due to both primary mechanical injury and secondary inflammatory responses, encompassing glial scar formation and axonal disruption. Despite advancements in pain management, surgery, and cell therapies, these conditions remain difficult to treat effectively. This review examines recent developments in hydrogel materials for spinal surgery, with a focus on their applications in the treatment of IVDD and SCI. Hydrogels, due to their biocompatibility, tunable mechanical properties, and ability to mimic the native ECM, have shown enormous promise in spinal repair. Their high water content and porous structure enable the efficient delivery of drugs and cells, and their injectability makes them useful for minimally invasive procedures. Hydrogels offer potential in regenerating the nucleus pulposus, modulating inflammation, supporting axonal regrowth, and preventing fibrosis. Furthermore, their injectable and self-healing properties enable less invasive surgical interventions. While showing clear advantages, they continue to struggle with mechanical strength, controlled therapeutic delivery, and precise structural outcomes in 3D printing. Ongoing research is needed to optimize these properties for clinical applications. This review provides an overview of the biological mechanisms, material design, and fabrication techniques of hydrogels, aiming to support the future development of hydrogel-based therapies in spinal disorder treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.